Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

abx092223-100l 100 µl
EUR 650

Human IgG antibody Laboratories manufactures the units s/c for sars igg test reagents distributed by Genprice. The Units S/C For Sars Igg Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Units products are available in stock. Specificity: Units Category: S/C Group: For Sars

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

1 ml Ask for price

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

200 µl
EUR 350

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

100 µl
EUR 225

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

1 ml Ask for price

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

200 µl
EUR 350

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

100 µl
EUR 225

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

1 ml Ask for price

For Sars information

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-50g 50 µg
EUR 450

SARS-CoV-2 Antigen Rapid Test Kit

GF101A2 25 Test/kit Ask for price

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Replacement cables for CSQ Large Format Vertical Units - PK2

CSLCAB2 PK2
EUR 159.3

Purite Puricpac Pretreatment Cartridge PP16 for 320 Units - EACH

WAT2294 EACH
EUR 456.3

Monoclonal antibody to human IgG for rapid test

MBS596150-1mg 1mg
EUR 480

Monoclonal antibody to human IgG for rapid test

MBS596150-2mg 2mg
EUR 700

Monoclonal antibody to human IgG for rapid test

MBS596150-5mg 5mg
EUR 1505

Purite Pretreatment Cartridge PT8 for 40/80/160 Units - EACH

WAT2262 EACH
EUR 259.2

Purite Pretreatment Cartridge NCP8 for 40/80/160 Units - EACH

WAT3262 EACH
EUR 468.45

Spleen Colony-Forming Units (CFU-S) Inhibitor

070-18 500 μg
EUR 73.44

TesA, E. coli esterase, 100 units

0306-1 100 Units
EUR 304.9

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-100l 100 µl
EUR 650

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-1ml 1 ml
EUR 10500

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-200l 200 µl
EUR 2100

SARS-CoV-2-IgM/IgG-Test-Kit(Immunochromatographic-Assay)

EGIVD008 CE-recogniton-IVD
EUR 350
Description: CE recogniton IVD